In SLE, certain FCGR3A polymorphisms have been associated with increased disease risk (53); however, attempts to validate its increased expression by qPCR in SLE were unsuccessful (54), highlighting the complexity of transcriptomic-proteomic correlations. The gene discussed is FCGR3A; the disease is systemic lupus erythematosus.